Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study

Harm Reduction Journal

Volumn 3, Issue , 2006, Pages

  Wood, Evan ^a,b   Stoltz, Jo Anne ^a   Montaner, Julio S G ^a,b   Kerr, Thomas ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; CANADA; CRYSTAL; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; INTRAVENOUS DRUG ABUSE; MALE; METHODOLOGY; NORTH AMERICA; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

EID: 33745499248     PISSN: 14777517     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-3-18     Document Type: Article

References (47)

1. National Household Survey on Drug Abuse. In The NHSDA Report US Department of Health and Human Services. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA). March 14, 2003
2. Reducing the harm associated with injection drug use in Canada. Federal, Provincial and Territorial Advisory Committee on Population Health; 2001.
3. Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV, Schechter MT: Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr 2001, 28:351-357.
4. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K: Opiates, cocaine, and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 2003, 98:739-747.
5. Garfield J, Drucker E: Fatal overdose trends in major US cities: 1990-1997. Addictions Research and Theory 2001, 9:425-436.
6. Wood E, Tyndall MW, Spittal P, Li K, Kerr T, Hogg RS, Montaner JSG, O'Shaughnessy MV, Schechter MT: Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ 2001, 165:405-410.
7. Palepu A, Strathdee SA, Hogg RS, Anis AH, Rae S, Cornelisse PGA, Patrick DM, O'Shaughnessy MV, Schechter MT: The social determinants of emergency department and hospital use by injection drug users in Canada. J Urban Health 1999, 76:409-18.
8. Palepu A, Tyndall MW, Leon H, Muller J, O'Shaughnessy MV, Schechter MT, Anis AH: Hospital utilization and costs in a cohort of injection drug users. CMAJ 2001, 165:415-420.
9. Wall R, Rehm J, Fischer B, Brands B, Gliksman L, Stewart J, Medved W, Blake J: Social costs of untreated opioid dependence. J Urban Health 2000, 77:688-722.
10. Wood E, Kerr T, Spittal PM, Tyndall MW, O'Shaughnessy MV, Schechter MT: The healthcare and fiscal costs of the illicit drug use epidemic: the impact of conventional drug control strategies and the impact of a comprehensive approach. BCMJ 2003, 45:130-136.
11. Cases of HIV infection and AIDS in the United States, 2002 HIV/AIDS Surveillance Report 14: [http://www.cdc.gov/hiv/stats/hasr1402/table1.htm]. Centers for Disease Control and Prevention
12. Viral hepatitis and injection drug users 2002 [http://www.thebody.com/cdc/hepatitis_idus.html]. Centers for Disease Control and Prevention
13. Strathdee SA, Patrick DM, Currie SL, Cornelisse PGA, Rekart ML, Montaner JSG, Schechter MT, O'Shaughnessy MV: Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997, 11:F59-F65.
14. HIV and AIDS among youth in Canada. In HIV/AIDS Epi Update Centre for Infectious Disease Prevention and Control. Health Canada; 2003.
15. Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF: Drug injection among street youths in Montreal: predictors of initiation. J Urban Health 2003, 80:92-105.
16. Fuller CM, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee SA: Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr 2003, 32:86-93.
17. Pfeifer RW, Oliver J: A study of HIV seroprevalence in a group of homeless youth in Hollywood, California. J Adolesc Health 1997, 20:339-342.
18. Gleghorn AA, Marx R, Vittinghoff E, Katz MH: Association between drug use patterns and HIV risks among homeless, runaway, and street youth in northern California. Drug Alcohol Depend 1998, 51:219-227.
19. Kral AH, Molnar BE, Booth RE, Watters JK: Prevalence of sexual risk behavior and substance use among runaway and homeless adolescents in San Francisco, Denver and New York City. Int J STD AIDS 1997, 8:109-117.
20. Greene JM, Ennett ST, Ringwalt CL: Prevalence and correlates of survival sex among runaway and homeless youth. Am J Public Health 1999, 89:1406-1409.
21. Bringing street youth out of the shadows. CPS News 1998. May/June: 5-6
22. Ochnio JJ, Patrick D, Ho M, Talling DN, Dobson SR: Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ 2001, 165:293-297.
23. Roy E, Haley N, Leclerc P, Cedras L, Boivin JF: Drug injection among street youth: the first time. Addiction 2002, 97:1003-1009.
24. Stenbacka M: Initiation into intravenous drug abuse. Acta Psychiatr Scand 1990, 81:459-462.
25. Varescon I, Vidal-Trecan G, Gagniere B, Christoforov B, Boissonnas A: Risks incurred by the first intravenous drug injection. Ann Med Interne 2000, 151B:B5-B8.
26. Roy E, Haley N, Leclerc P, Cedras L, Weber AE, Claessens C, Boivin JF: HIV incidence among street youth in Montreal, Canada. AIDS 2003, 17:1071-1075.
27. Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA: High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend 2002, 66:189-198.
28. Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA: Factors associated with adolescent initiation of injection drug use. Public Health Rep 2001, 116(Suppl 1):136-145.
29. Roy E, Haley N, Leclerc P, Lemire N, Boivin JF, Frappier JY, Claessens C: Prevalence of HIV infection and risk behaviours among Montreal street youth. Int J STD AIDS 2000, 11:241-247.
30. Neaigus A, Miller M, Friedman SR, Hagen DL, Sifaneck SJ, Ildefonso G, des Jarlais DC: Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001, 96:847-860.
31. Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC: Updating the Infection Risk Reduction Hierarchy: Preventing Transition into Injection. J Urban Health 2004, 81:14-19.
32. Clatts MC, Goldsamt L, Neaigus A, Welle DL: The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research. J Urban Health 2003, 80:26-39.
33. Suh T, Mandell W, Latkin C, Kim J: Social network characteristics and injecting HIV-risk behaviors among street injection drug users. Drug Alcohol Depend 1997, 47:137-143.
34. van Ameijden EJ, Coutinho RA: Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS 1998, 12:625-633.
35. Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW: Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis 2004, 4:301-306.
36. Des Jarlais DC, Lyles C, Crepaz N: Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004, 94:361-366.
37. Douglas D, Broadhead RS: A new approach to sampling hidden populations: respondent-driven sampling. Int Conf AIDS 1996, 11:231.
38. Heckathorn D, Broadhead RS: Respondent-driven sampling: a new approach to sampling hidden populations. Int Conf AIDS 1998, 12:928.
39. Thompson SK, Collins LM: Adaptive sampling in research on risk-related behaviors. Drug Alcohol Depend 2002, 68(Suppl 1):S57-S67.
40. Safaeian M, Brookmeyer R, Vlahov D, Latkin C, Marx M, Strathdee SA: Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. Am J Epidemiol 2002, 155:169-175.
41. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, Schechter MT: Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003, 17:887-893.
42. Wood E, Li K, Miller CL, Hogg RS, Montaner JS, Schechter MT, Kerr T: Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users. Int J Epidemiol 2005, 34:152-158.
43. Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW: Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ 2004, 171:731-734.
44. Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977, 1:385-401.
45. Childhood Trauma Questionnaire (CTQ). Copyright 1998 by The Psychological Corporation, Harcourt, Brace, and Co., San Antonio.
46. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, Zule W: Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 2003, 27:169-190.
47. Carey MP, Schroder KEE: Development and psychometric evaluation of the brief HIV Knowledge Questionnaire. AIDS Educ Prev 2002, 14:172-182.